Key facts
- This page summarizes Marcus Lemonis's Form 4 filing for BED BATH & BEYOND, INC. (BBBY).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 06 Feb 2026, 16:09.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Award
Additional SEC filing notes
Footnote F1
Each performance share represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. On March 10, 2025 the reporting person was granted an award of performance shares, which are scheduled to vest in three equal installments at the close of business on March 10, 2026, March 10, 2027, and March 10, 2028, subject to and upon the satisfaction of certain performance criteria. On February 4, 2026, the compensation committee of the Issuer's board of directors determined that a total of 424,300 performance shares were earned based on performance relative to the performance criteria for fiscal year 2025. Accordingly, the earned performance shares will vest based on continued service through the applicable vesting date specified above.
Footnote F2
Represents warrants that were originally issued on October 7, 2025 as a pro-rata distribution to all holders of common stock. Each warrant entitles the holder to purchase one share of the Registrant's common stock at an exercise price of $15.50 per warrant. This distribution was exempt from immediate reporting under Section 16.